Biocon Biologics New Monoclonal Antibodies Manufacturing Facility Wins ISPE s 2021 Facility of the Year Honorable Mention Award equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
2021 ISPE Facility of the Year Awards Winners Announced prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Government Pharmaceutical Organization of Thailand via Agence France-Presse/Getty Images
hide caption
toggle caption Government Pharmaceutical Organization of Thailand via Agence France-Presse/Getty Images
As the U.S. races to vaccinate its population, the development of better COVID-19 vaccines has already begun. Government Pharmaceutical Organization of Thailand via Agence France-Presse/Getty Images
The three COVID-19 vaccines available in the United States are safe and effective and were made in record time.
But they aren t ideal.
An ideal vaccine besides being safe and effective would have a few other desirable characteristics, says Deborah Fuller, a vaccine researcher at the University of Washington.